GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

13.07.23	GSK is first to ship influenza vaccine doses for the 2023-24 flu season in US (Businesswire)
21.06.23	GSK shares positive data for AREXVY, its respiratory syncytial virus (RSV) older adult vaccine, indicating protection over two RSV seasons (Businesswire)
20.06.23	GSK and Lifetime® Release Short Film Featuring Soleil Moon Frye and Melissa Joan Hart Urging Parents to "Ask2BSure” about Meningitis B (Businesswire)
01.06.23	GSK Announces the COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the US (Businesswire)
03.05.23	US FDA Approves GSK’s AREXVY, the World’s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults (Businesswire)
14.03.23	GSK and Earvin "Magic” Johnson Partner to Raise Awareness of Risk of RSV in Older Adults (Businesswire)
11.12.22	New data at ASH underscore the potential for durable, clinically important responses with momelotinib for myelofibrosis patients (Businesswire)
07.06.22	Hardman & Co Life Sciences Research: Long-term pharmaceutical industry cost and EBIT analysis (EQS Group)
06.08.20	FDA Approves GSK’s BLENREP (belantamab mafodotin-blmf) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (Businesswire)
24.04.20	GSK Presents New Data from the GARNET Study Demonstrating Potential of Dostarlimab to Treat a Subset of Women with Recurrent or Advanced Endometrial Cancer (Businesswire)
23.10.19	GSK Announces U.S. Food and Drug Administration Approval of Additional Indication for Zejula (niraparib) for Late-line Treatment for Women with Recurrent Ovarian Cancer (Businesswire)
23.03.18	ViiV Healthcare Gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe (Businesswire)
24.07.13	GlaxoSmithKline CFO Interviewed on Q2 Results (PR Newswire)
24.07.13	GlaxoSmithKline CFO Interviewed on Q2 Results (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

CieFinRichemont	136.55	1.30 %	K V
Logitech Intl	74.04	1.18 %	K V
Holcim	87.08	1.14 %	K V
Roche Hldg G	250.20	1.13 %	K V
UBS Group	27.00	1.09 %	K V
Lonza Grp	533.20	0.41 %	K V
Alcon	76.26	0.32 %	K V
Sonova Hldg	296.40	0.27 %	K V
Nestle	73.96	-0.03 %	K V
Geberit	513.00	-0.23 %	K V

mehr

27.07.22		GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an
18.07.22		Haleon-Aktie etwas tiefer: GSK-Abspaltung Haleon wird erstmals in London gehandelt
23.06.22		GSK-Aktie in Grün: GSK will Infektionskrankheiten in armen Ländern bekämpfen
06.06.22		GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten
01.06.22		GSK-Aktie schwach: GlaxoSmithKline will Konsumentensparte Mitte Juli an die Börse bringen - Pfizer steigt aus
31.05.22		GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal
27.04.22		GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen
27.04.22		Ausblick: GlaxoSmithKline gewährt Anlegern Blick in die Bücher